ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Press Information

ASN Press Releases: 2022 Archives

HOW HAVE CHANGES IN ANEMIA CARE AFFECTED PATIENTS WITH KIDNEY FAILURE?

Latest Release: HOW HAVE CHANGES IN ANEMIA CARE AFFECTED PATIENTS WITH KIDNEY FAILURE?

Thursday, May 19, 2022
• 2011 changes in policies and recommendations related to the use of erythropoietin-stimulating agents were associated with lower hemoglobin levels and lower risks of major adverse cardiovascular events, mortality, and stroke among adults receiving hemodialysis, but with a higher risk of heart attack.

View Press Release

Subscribe to ASN Press Releases

Stay on top of the latest happenings with the Society and in the nephrology world by subscribing to the ASN Press Release RSS Feed.


More Press Releases

  • DOES THE DRUG DAPAGLIFLOZIN BENEFIT HOSPITALIZED PATIENTS WITH COVID-19?
    • In hospitalized patients with COVID-19, the SGLT2 inhibitor dapagliflozin was well tolerated regardless of kidney function, but did not significantly lower patients' risk of organ failure, kidney problems, or death compared with placebo.
    Thursday, April 28, 2022
  • NEW TOOL ASSESSES PATIENTS' KIDNEY DISEASE–RELATED KNOWLEDGE
    • Researchers have developed and validated a new instrument to measure CKD- and transplant-related knowledge in a racially, ethnically, and linguistically diverse group of patients with moderate to severe chronic kidney disease.
    Thursday, March 24, 2022
  • AMERICAN SOCIETY OF NEPHROLOGY AND AMERICAN ASSOCIATION OF KIDNEY PATIENTS SEEK CONGRESSIONAL SUPPORT FOR KIDNEY RESEARCH AND INNOVATION RENEW REQUEST FOR LIVING ORGAN DONOR PROTECTIONS
    • Today advocates of the American Society of Nephrology (ASN) and American Association of Kidney Patients (AAKP) will meet with their Congressional delegations to ask for new policies to improve kidney health for 37 million Americans living with kidney diseases • Congress will be asked to increase funding for kidney health research at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Congress will be asked to accelerate innovation by increasing investment in KidneyX • Congress will be asked to protect insured and uninsured living organ donors, legislation such as the Living Donor Protection Act (H.R. 1255/S. 377) seeks to remove barriers to living organ donation
    Wednesday, March 23, 2022
  • RESEARCHERS IDENTIFY COST BARRIERS TO MORE WIDESPREAD USE OF PERITONEAL DIALYSIS
    • There's a push to transition dialysis care in the United States from in-center to home-based dialysis (including peritoneal dialysis), but a new review has identified several cost considerations that limit the use of peritoneal dialysis. • Addressing these barriers may help to incentivize a switch to peritoneal dialysis.
    Monday, March 21, 2022
  • Global Kidney Organizations Appeal for Kidney Health for All War Victims
    As we observe World Kidney Day 2022 and recognize all the incredible advances in our field, we must pause and remember members of the kidney community in war-torn countries. This year's World Kidney Day theme, "Kidney Health for All," underscores harsh inequities that currently exist around the world. Global attention is currently on the war in Ukraine; many other countries—such as Afghanistan, Cameroon, Ethiopia, Iraq, Libya, Sudan, Syria, and Yemen—are also in conflict.
    Thursday, March 10, 2022
  • COVID-19 VACCINATION PROTECTS ADULTS ON DIALYSIS AGAINST INFECTION AND SEVERE DISEASE
    • Compared with individuals on dialysis who were not vaccinated against COVID-19, those who had received 2 mRNA vaccine doses were 69% and 83% less likely to become infected or experience severe disease, respectively. • There were no significant differences in vaccine effectiveness among age groups, mode of dialysis, or vaccine type.
    Wednesday, March 9, 2022
  • STUDY EXAMINES USE OF PALLIATIVE CARE FOR PATIENTS WITH COVID-19 AND ACUTE KIDNEY INJURY
    • In an observational study involving several New York City hospitals, palliative care was used more frequently for hospitalized patients with acute kidney injury (AKI) and COVID-19 than historically reported in AKI. • Despite high mortality associated with AKI, consultation for palliative care occurred late in the hospital course and was not associated with reduced initiation of life sustaining interventions.
    Thursday, February 24, 2022
  • NEW DATA ON THE EFFECTS OF COVID-19 VACCINATION IN PATIENTS ON DIALYSIS
    • Results from a study from France suggest that both individual and herd vaccine-induced immunity protect against severe forms of COVID-19 in patients on dialysis. • A U.S. study found that antibody responses following COVID-19 vaccination wane over time across vaccine types in patients on dialysis.
    Thursday, February 10, 2022
  • IMPROVING MODELS TO PREDICT CARDIOVASCULAR DISEASE IN INDIVIDUALS WITH KIDNEY DYSFUNCTION
    • Several factors not included in prior prediction models were important for atherosclerotic cardiovascular disease prediction among patients with chronic kidney disease. • Adding these factors could aid clinicians and patients with decisions related to heart disease prevention.
    Thursday, February 10, 2022
  • STUDY REVEALS HIGH DEATH RATES ASSOCIATED WITH ACUTE KIDNEY INJURY IN HOSPITALIZED VETERANS
    • Among veterans with acute kidney injury (AKI) at some point between 2008 to 2017, 6% died in-hospital and 28% died within 1 year. In contrast, in-hospital and one-year mortality was 0.8% and 14%, respectively, among non-AKI hospitalizations. • In veterans hospitalized with AKI, in-hospital and one-year mortality rates remained stable throughout the study period.
    Monday, February 7, 2022
  • PATIENT AND CAREGIVER EXPERIENCES AND ATTITUDES ABOUT THEIR INVOLVEMENT IN KIDNEY DISEASE RESEARCH
    • Interviews of adults with chronic kidney disease and their caregivers who had previously been involved in kidney disease–related research identified various factors that supported their involvement or created challenges to participation.
    Monday, February 7, 2022
  • HEALTH-RELATED QUALITY-OF-LIFE DIFFERENCES IN MEN AND WOMEN WITH ADVANCED KIDNEY DISEASE
    • At the start of a study of older adults with advanced kidney disease, women had lower average physical and mental health-related quality-of-life scores compared with men. • Over time, however, both physical and mental scores declined approximately twice as fast in men than in women.
    Monday, January 24, 2022
  • HOW WOULD ELIMINATING RACE-BASED ADJUSTMENTS IN ESTIMATES OF KIDNEY FUNCTION IMPACT CLINICAL TRIALS?
    • In an analysis of data from a recent clinical trial, researchers found that removing a race-based adjustment in the estimation of individuals' kidney function had a small but potentially important impact on the inclusion of participants, with differing effects on Black and non-Black participants. • Removal of the race-based adjustment also influenced inclusion parameters such as participants' severity of kidney function impairment at baseline as well as their risk of developing cardiovascular- and kidney-related outcomes.
    Friday, January 21, 2022
  • COVID-19 and its Impact on Kidney Patients Utilizing U.S. Dialysis Centers
    A joint statement from the National Kidney Foundation and the American Society of Nephrology January 18, 2022 The National Kidney Foundation (NKF) and the American Society of Nephrology (ASN) stress the precarious position people with kidney failure, who are immunocompromised, face as the recent Omicron wave continues to spread among patients and staff at dialysis facilities. Cases of COVID-19 are causing serious illness, forcing shortened treatment times for patients, and exacerbating shortages in staff and supplies that impede access to this life-sustaining treatment. COVID-19's impact on people with kidney diseases has resulted in the first decline in the number of patients on dialysis in the United States in the 50-year history of the Medicare ESRD Program.
    Tuesday, January 18, 2022